Catalyst Pharmaceuticals, Inc.
US ˙ NasdaqCM ˙ US14888U1016

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in CPRX / Catalyst Pharmaceuticals, Inc.

On May 14, 2025 - Group One Trading, L.p. filed a 13F-HR/A form disclosing ownership of 0 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $0 USD as of December 31, 2024. The entity filed a previous 13F-HR on November 14, 2024 disclosing 8,108 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (CPRX) in the form of stock options. The firm currently holds call options representing 13,100 of underlying shares valued at $305,754 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CPRX / Catalyst Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-05-14 2024-12-31 13F/A-1 CATALYST PHARMACEUTICALS COM 14888U101 0 -8,108 -100.00 0 -100.00
2025-02-14 2024-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 0 -8,108 0
2024-11-14 2024-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 8,108 -7,559 -48.25 161 -33.47 0.0005
2024-08-14 2024-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 15,667 4,657 42.30 243 38.29 0.0009
2024-05-10 2024-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 11,010 11,010 175 0.0007
2022-08-11 2022-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 0 -9,242 -100.00 0 -100.00
2022-05-12 2022-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 9,242 3,689 66.43 77 102.63 0.0001
2022-02-11 2021-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 5,553 -21,503 -79.48 38 -73.43 0.0000
2021-11-12 2021-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 27,056 -78,192 -74.29 143 -76.36 0.0002
2021-08-10 2021-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 105,248 105,248 605 0.0007
2020-08-13 2020-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 0 -201,698 -100.00 0 -100.00
2020-05-13 2020-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 201,698 37,795 23.06 777 26.34 0.0063
2020-02-10 2019-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 163,903 -22,895 -12.26 615 -38.00 0.0042
2019-11-12 2019-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 186,798 149,586 401.98 992 593.71 0.0080
2019-08-09 2019-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 37,212 37,212 -80.08 143 -85.58 0.0013
2019-05-14 2019-03-31 13F/A-1 CATALYST PHARMACEUTICALS COM 14888U101 0 -16,764 -100.00 0 -100.00
2019-02-05 2018-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 16,764 2,458 17.18 32 -40.74 0.0003
2018-11-08 2018-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 14,306 2,082 17.03 54 42.11 0.0004
2018-08-13 2018-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 12,224 10,239 515.82 38 660.00 0.0003
2018-05-16 2018-03-31 13F/A-1 CATALYST PHARMACEUTICALS COM 14888U101 1,985 411 26.11 5 -16.67 0.0001
2018-05-10 2018-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 1,985 411 5
2018-02-09 2017-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 1,574 -979 -38.35 6 0.00 0.0000
2017-11-15 2017-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 2,553 2,553 62.20 6 0.00 0.0001
2016-05-12 2016-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 0 0 0 0.0000
2016-02-11 2015-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 0 -1,398 -100.00 0 -100.00
2015-11-20 2015-09-30 13F/A-1 CATALYST PHARMACEUTICALS COM 14888U101 1,398 1,398 0.00 4 0.00 0.0001
2015-11-06 2015-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 1,398 4
2014-10-31 2014-09-30 13F CATALYST PHARM PARTNERS COM 14888U101 0 -26,248 -100.00 0 -100.00
2014-08-12 2014-06-30 13F CATALYST PHARM PARTNERS COM 14888U101 26,248 13,572 107.07 66 127.59 0.0010
2014-05-07 2014-03-31 13F CATALYST PHARM PARTNERS COM 14888U101 12,676 -224 -1.74 29 16.00 0.0005
2014-01-31 2013-12-31 13F CATALYST PHARM PARTNERS COM 14888U101 12,900 12,900 25 0.0004
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F CATALYST PHARMACEUTICALS COM Call 13,100 -12.67 306 3.39 n/a n/a n/a
2025-11-12 2025-09-30 13F CATALYST PHARMACEUTICALS COM Call 15,000 7.91 296 -1.99 n/a n/a n/a
2025-08-14 2025-06-30 13F CATALYST PHARMACEUTICALS COM Call 13,900 -72.58 302 -75.51 n/a n/a n/a
2025-05-14 2025-03-31 13F CATALYST PHARMACEUTICALS COM Call 50,700 934.69 1,229 1,104.90 n/a n/a n/a
2025-05-14 2024-12-31 13F/A CATALYST PHARMACEUTICALS COM Call 4,900 -51.00 102 -48.48 n/a n/a n/a
2025-02-14 2024-12-31 13F CATALYST PHARMACEUTICALS COM Call 4,900 102 n/a n/a n/a
2024-11-14 2024-09-30 13F CATALYST PHARMACEUTICALS COM Call 10,000 614.29 199 842.86 n/a n/a n/a
2024-08-14 2024-06-30 13F CATALYST PHARMACEUTICALS COM Call 1,400 -97.28 22 -97.44 n/a n/a n/a
2024-05-10 2024-03-31 13F CATALYST PHARMACEUTICALS COM Call 51,500 -70.80 821 -72.34 n/a n/a n/a
2024-02-14 2023-12-31 13F CATALYST PHARMACEUTICALS COM Call 176,400 500.00 2,965 764.43 n/a n/a n/a
2023-11-09 2023-09-30 13F CATALYST PHARMACEUTICALS COM Call 29,400 -58.71 344 -64.12 n/a n/a n/a
2023-08-09 2023-06-30 13F CATALYST PHARMACEUTICALS COM Call 71,200 -87.96 957 -90.25 n/a n/a n/a
2023-05-12 2023-03-31 13F CATALYST PHARMACEUTICALS COM Call 591,200 1,628.65 9,802 1,441.19 n/a n/a n/a
2023-02-09 2022-12-31 13F CATALYST PHARMACEUTICALS COM Call 34,200 -22.97 636 11.58 n/a n/a n/a
2022-11-09 2022-09-30 13F CATALYST PHARMACEUTICALS COM Call 44,400 10.17 570 101.41 n/a n/a n/a
2022-08-11 2022-06-30 13F CATALYST PHARMACEUTICALS COM Call 40,300 27.94 283 8.43 n/a n/a n/a
2022-05-12 2022-03-31 13F CATALYST PHARMACEUTICALS COM Call 31,500 146.09 261 200.00 n/a n/a n/a
2022-02-11 2021-12-31 13F CATALYST PHARMACEUTICALS COM Call 12,800 -79.45 87 -73.64 n/a n/a n/a
2021-11-12 2021-09-30 13F CATALYST PHARMACEUTICALS COM Call 62,300 294.30 330 262.64 n/a n/a n/a
2021-08-10 2021-06-30 13F CATALYST PHARMACEUTICALS COM Call 15,800 -79.02 91 -73.78 n/a n/a n/a
2021-05-12 2021-03-31 13F CATALYST PHARMACEUTICALS COM Call 75,300 736.67 347 1,056.67 n/a n/a n/a
2021-02-10 2020-12-31 13F CATALYST PHARMACEUTICALS COM Call 9,000 -89.61 30 -88.33 n/a n/a n/a
2020-11-12 2020-09-30 13F CATALYST PHARMACEUTICALS COM Call 86,600 25.69 257 -19.18 n/a n/a n/a
2020-08-13 2020-06-30 13F CATALYST PHARMACEUTICALS COM Call 68,900 122.26 318 167.23 n/a n/a n/a
2020-05-13 2020-03-31 13F CATALYST PHARMACEUTICALS COM Call 31,000 13.97 119 14.42 n/a n/a n/a
2019-08-09 2019-06-30 13F CATALYST PHARMACEUTICALS COM Call 27,200 39.49 104 5.05 n/a n/a n/a
2019-05-14 2019-03-31 13F/A CATALYST PHARMACEUTICALS COM Call 19,500 248.21 99 800.00 n/a n/a n/a
2019-05-13 2019-03-31 13F CATALYST PHARMACEUTICALS COM Call 19,500 99 n/a n/a n/a
2019-02-05 2018-12-31 13F CATALYST PHARMACEUTICALS COM Call 5,600 180.00 11 37.50 n/a n/a n/a
2018-11-08 2018-09-30 13F CATALYST PHARMACEUTICALS COM Call 2,000 0.00 8 33.33 n/a n/a n/a
2018-08-13 2018-06-30 13F CATALYST PHARMACEUTICALS COM Call 2,000 0.00 6 -25.00 n/a n/a n/a
2018-05-16 2018-03-31 13F/A CATALYST PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-09 2017-12-31 13F CATALYST PHARMACEUTICALS COM Call 100 0.00 0 n/a n/a n/a
2017-11-15 2017-09-30 13F CATALYST PHARMACEUTICALS COM Call 100 -99.90 0 -100.00 n/a n/a n/a
2017-08-14 2017-06-30 13F CATALYST PHARMACEUTICALS COM Call 100,000 17.65 276 66.27 n/a n/a n/a
2017-05-10 2017-03-31 13F CATALYST PHARMACEUTICALS COM Call 85,000 -15.00 166 -39.86 n/a n/a n/a
2015-11-06 2015-09-30 13F CATALYST PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-11 2015-06-30 13F CATALYST PHARMACEUTICALS COM Call 87,300 220.96 361 205.93 n/a n/a n/a
2015-05-14 2015-03-31 13F CATALYST PHARM PARTNERS COM Call 27,200 -41.25 118 -14.49 n/a n/a n/a
2015-02-11 2014-12-31 13F CATALYST PHARM PARTNERS COM Call 46,300 -59.35 138 -63.49 n/a n/a n/a
2014-10-31 2014-09-30 13F CATALYST PHARM PARTNERS COM Call 113,900 2,548.84 378 4,625.00 n/a n/a n/a
2014-01-31 2013-12-31 13F CATALYST PHARM PARTNERS COM Call 4,300 8 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F CATALYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-12 2025-09-30 13F CATALYST PHARMACEUTICALS COM Put 300 -62.50 6 -70.59 n/a n/a n/a
2025-08-14 2025-06-30 13F CATALYST PHARMACEUTICALS COM Put 800 60.00 17 41.67 n/a n/a n/a
2025-05-14 2025-03-31 13F CATALYST PHARMACEUTICALS COM Put 500 12 n/a n/a n/a
2025-05-14 2024-12-31 13F/A CATALYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F CATALYST PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2024-11-14 2024-09-30 13F CATALYST PHARMACEUTICALS COM Put 25,400 -15.89 505 7.92 n/a n/a n/a
2024-08-14 2024-06-30 13F CATALYST PHARMACEUTICALS COM Put 30,200 105.44 468 99.57 n/a n/a n/a
2024-05-10 2024-03-31 13F CATALYST PHARMACEUTICALS COM Put 14,700 -77.35 234 -78.53 n/a n/a n/a
2024-02-14 2023-12-31 13F CATALYST PHARMACEUTICALS COM Put 64,900 1,654.05 1,091 2,434.88 n/a n/a n/a
2023-11-09 2023-09-30 13F CATALYST PHARMACEUTICALS COM Put 3,700 -85.26 43 -87.24 n/a n/a n/a
2023-08-09 2023-06-30 13F CATALYST PHARMACEUTICALS COM Put 25,100 709.68 337 560.78 n/a n/a n/a
2023-05-12 2023-03-31 13F CATALYST PHARMACEUTICALS COM Put 3,100 416.67 51 363.64 n/a n/a n/a
2023-02-09 2022-12-31 13F CATALYST PHARMACEUTICALS COM Put 600 -95.45 11 -93.49 n/a n/a n/a
2022-11-09 2022-09-30 13F CATALYST PHARMACEUTICALS COM Put 13,200 169 n/a n/a n/a
2022-08-11 2022-06-30 13F CATALYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-12 2022-03-31 13F CATALYST PHARMACEUTICALS COM Put 1,000 900.00 8 700.00 n/a n/a n/a
2022-02-11 2021-12-31 13F CATALYST PHARMACEUTICALS COM Put 100 -99.79 1 -99.61 n/a n/a n/a
2021-11-12 2021-09-30 13F CATALYST PHARMACEUTICALS COM Put 47,900 -17.13 254 -23.49 n/a n/a n/a
2021-08-10 2021-06-30 13F CATALYST PHARMACEUTICALS COM Put 57,800 1,079.59 332 1,343.48 n/a n/a n/a
2021-05-12 2021-03-31 13F CATALYST PHARMACEUTICALS COM Put 4,900 157.89 23 283.33 n/a n/a n/a
2021-02-10 2020-12-31 13F CATALYST PHARMACEUTICALS COM Put 1,900 -61.22 6 -73.91 n/a n/a n/a
2020-11-12 2020-09-30 13F CATALYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F CATALYST PHARMACEUTICALS COM Put 4,000 -4.76 18 12.50 n/a n/a n/a
2020-05-13 2020-03-31 13F CATALYST PHARMACEUTICALS COM Put 4,200 -74.07 16 -73.77 n/a n/a n/a
2020-02-10 2019-12-31 13F CATALYST PHARMACEUTICALS COM Put 16,200 -52.07 61 -65.92 n/a n/a n/a
2019-11-12 2019-09-30 13F CATALYST PHARMACEUTICALS COM Put 33,800 -48.00 179 -28.40 n/a n/a n/a
2019-08-09 2019-06-30 13F CATALYST PHARMACEUTICALS COM Put 65,000 1.72 250 -23.31 n/a n/a n/a
2019-05-14 2019-03-31 13F/A CATALYST PHARMACEUTICALS COM Put 63,900 43.92 326 283.53 n/a n/a n/a
2019-05-13 2019-03-31 13F CATALYST PHARMACEUTICALS COM Put 63,900 326 n/a n/a n/a
2019-02-05 2018-12-31 13F CATALYST PHARMACEUTICALS COM Put 44,400 124.24 85 13.33 n/a n/a n/a
2018-11-08 2018-09-30 13F CATALYST PHARMACEUTICALS COM Put 19,800 -55.41 75 -11.76 n/a n/a n/a
2018-08-13 2018-06-30 13F CATALYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-16 2018-03-31 13F/A CATALYST PHARMACEUTICALS COM Put 5,000 0.00 12 -40.00 n/a n/a n/a
2018-05-10 2018-03-31 13F CATALYST PHARMACEUTICALS COM Put 5,000 12 n/a n/a n/a
2018-02-09 2017-12-31 13F CATALYST PHARMACEUTICALS COM Put 5,000 -77.17 20 -63.64 n/a n/a n/a
2017-11-15 2017-09-30 13F CATALYST PHARMACEUTICALS COM Put 21,900 -17.67 55 -24.66 n/a n/a n/a
2017-08-14 2017-06-30 13F CATALYST PHARMACEUTICALS COM Put 26,600 21.46 73 32.73 n/a n/a n/a
2015-11-06 2015-09-30 13F CATALYST PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-11 2015-06-30 13F CATALYST PHARMACEUTICALS COM Put 500 2 n/a n/a n/a
2015-05-14 2015-03-31 13F CATALYST PHARM PARTNERS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-11 2014-12-31 13F CATALYST PHARM PARTNERS COM Put 15,600 -51.70 46 -57.01 n/a n/a n/a
2014-10-31 2014-09-30 13F CATALYST PHARM PARTNERS COM Put 32,300 447.46 107 613.33 n/a n/a n/a
2014-08-12 2014-06-30 13F CATALYST PHARM PARTNERS COM Put 5,900 883.33 15 1,400.00 n/a n/a n/a
2014-05-07 2014-03-31 13F CATALYST PHARM PARTNERS COM Put 600 -50.00 1 -50.00 n/a n/a n/a
2014-01-31 2013-12-31 13F CATALYST PHARM PARTNERS COM Put 1,200 2 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.